Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers
Biosensors and Bioelectronics · 2024
DOI: 10.1016/j.bios.2024.116347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024. Verfasst von Jinyoung Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro 50, Seoul, 120-749, Republic of Korea. Hauptthemen laut MEDLINE: Trastuzumab, Exosomes, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Korea Environmental Industry and Technology Institute, Korea Ministry of Science and ICT, Korea Research Institute of Bioscience and Biotechnology.
Abstract (Originalsprache)
Monitoring drug efficacy is significant in the current concept of companion diagnostics in metastatic breast cancer. Trastuzumab, a drug targeting human epidermal growth factor receptor 2 (HER2), is an effective treatment for metastatic breast cancer. However, some patients develop resistance to this therapy; therefore, monitoring its efficacy is essential. Here, we describe a deep learning-assisted monitoring of trastuzumab efficacy based on a surface-enhanced Raman spectroscopy (SERS) immunoassay against HER2-overexpressing mouse urinary exosomes. Individual Raman reporters bearing the desired SERS tag and exosome capture substrate were prepared for the SERS immunoassay; SERS tag signals were collected to prepare deep learning training data. Using this deep learning algorithm, various complicated mixtures of SERS tags were successfully quantified and classified. Exosomal antigen levels of five types of cell-derived exosomes were determined using SERS-deep learning analysis and compared with those obtained via quantitative reverse transcription polymerase chain reaction and western blot analysis. Finally, drug efficacy was monitored via SERS-deep learning analysis using urinary exosomes from trastuzumab-treated mice. Use of this monitoring system should allow proactive responses to any treatment-resistant issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro 50, Seoul, 120-749, Republic of Korea.
- Department of Radiology, Yonsei University, Seoul, 03772, Republic of Korea; Severance Biomedical Science Institute, Yonsei University, Seoul, 03772, Republic of Korea; YUHS-KRIBB Medical Convergence Research Institute,…
- Department of Radiology, Yonsei University, Seoul, 03772, Republic of Korea.
- Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea; Department of Nanobiotechnology, KRIBB School of Biotechnology, University of Scien…
- Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro 50, Seoul, 120-749, Republic of Korea. Electronic address: haam@yonsei.ac.kr.
Förderung
- Korea Environmental Industry and Technology Institute
- Korea Ministry of Science and ICT
- Korea Research Institute of Bioscience and Biotechnology
- National Research Council of Science and Technology
- Ministry of Science ICT and Future Planning
- Ministry of Science, ICT and Future Planning
- National Research Foundation of Korea
- Ministry of Education - Singapore
Zitieren
APA
Kim, J., Son, H. Y., Lee, S., Rho, H. W., Kim, R., Jeong, H., Park, C., Mun, B., Moon, Y., Jeong, E., Lim, E. K., & Haam, S. (2024). Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2024.116347
Vancouver
Kim J, Son HY, Lee S, Rho HW, Kim R, Jeong H, et al. Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers. Biosensors and Bioelectronics. 2024. doi:10.1016/j.bios.2024.116347
BibTeX
@article{Kim2024,
author = {Kim, Jinyoung and Son, Hye Young and Lee, Sojeong and Rho, Hyun Wook and Kim, Ryunhyung and Jeong, Hyein and Park, Chaewon and Mun, Byeonggeol and Moon, Yesol and Jeong, Eunji and Lim, Eun-Kyung and Haam, Seungjoo},
title = {Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers},
journal = {Biosensors and Bioelectronics},
year = {2024},
doi = {10.1016/j.bios.2024.116347}
}
EUVIMED